Quantitative molecular grading of bladder tumours: A tool for objective assessment of the biological potential of urothelial neoplasias

Oncology Reports

Volumn 21, Issue 1, 2009, Pages 39-47

  Bollman, Daniel ^a   Bollmann, Magdolna ^a   Bankfalvi, Agnes ^b   Heller, Hildegard ^a   Bollmann, Reinhard ^a   Pajor, Gabor ^c   Hildenbrand, Ralf ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Biomarkers; Bladder cancer; Image morphometry; Molecular grading; Prognosis

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN P53; MIB1 PROTEIN, HUMAN; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; PATIENT CODING; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR RECURRENCE; UROGENITAL TRACT TUMOR; BIOSYNTHESIS; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; MALE; MIDDLE AGED; PLOIDIES; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; URINARY BLADDER NEOPLASMS;

EID: 61449444345     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000187     Document Type: Article

References (26)

1. Knowles MA: Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27: 361-373, 2006.
2. Kurth KH, Denis L, Bouffioux C, et al: Factors affecting recurrence and progression in superficial bladder tumors. Eur J Cancer 31A: 1840-1846, 1995.
3. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, et al: Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163: 73-78, 2000.
4. Tosoni I, Wagner U, Sauter G, et al: Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. Br J Urol Int 85: 48-53, 2000.
5. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49: 466-475, 2006.
6. Cordon-Cardo C, Cote RJ and Sauter G: Genetic and molecular markers of urothelial premalignancy and malignancy. Scand J Urol Nephrol 205: 82-93, 2000.
7. Schultz IJ, Witjes AJ, Swinkels DW and de Kok JB: Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on surviving. Clinica Chimica Acta 368: 20-32, 2006.
8. Lopez-Knowles E, Hernandez S, Kogevinas M, et al: The p53 pathway and outcome among patients with T1G3 bladder tumors. Clin Cancer Res 12: 6029-6036, 2006.
9. Quintero A, Alvarez-Kindelan J, Luque RJ, et al: Ki-67 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder. J Clin Pathol 59: 83-88, 2006.
10. Pich A, Chiusa L, Formiconi A, et al: Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 95: 784-790, 2002.
11. Holmang S, Andius P, Hedelin H, et al: Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical statement of tumor markers, mitotic frequency and DNA ploidy. J Urol 165: 1124-1128, 2001.
12. Masters JR, Camplejohn RS, Parkinson MC, et al: DNA ploidy and the prognosis of stage pT1 bladder cancer. Br J Urol 64: 403-408, 1989.
13. Korkolopoulou P, Christodoulou P, Konstantinidou AE, et al: Cell cycle regulators in bladder cancer: A multivariate survival study with emphasis on p27Kip1. Hum Pathol 31: 751-760, 2000.
14. Shariat SF, Zlotta SR, Ashfaq R, Sagalowsky AI and Lotan Y: Cooperative effect of cell cycle regulators expression in bladder cancer development and biologic aggressiveness. Mod Pathol 20: 445-459, 2007.
15. van Rhijn BW, Vis AN, van der Kwast TH, et al: Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome. J Clin Oncol 21: 1912-1921, 2003.
16. Bollmann M, Heller H, Bánkfalvi A, Griefingolt H and Bollmann R: Quantitative molecular urinary cytology by UroVysion FISH: a tool for tailoring surveillance of patients with superficial bladder cancer? Br J Urol Int 95: 1219-1225, 2005.
17. Sobin LH and Wittekind Ch (eds): TNM Classification of Malignant Tumors, 6th edition. Wiley-Liss, Inc., Chichester, 2002.
18. Mostofi FK, Davis CJ and Sesterhenn IA: Histological typing of urinary bladder tumors. In: World Health Organisation. 2nd edition, Springer Verlag, Berlin, 1999.
19. Sauter G, Algaba F, Amin F, et al: Non-invasive urothelial neoplasias. WHO-classification of non-invasive papillary urothelial tumors. In: World Health Organization Classification of Tumors. Pathology and Genetics: Tumors of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein JI and Sesterhenn I (eds). IARCC Press, Lyon, pp89-157, 2004.
20. Cina SJ, Lancaster-Weiss KJ, Lecksell K and Epstein JI: Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasias. Arch Pathol Lab Med 125: 646-651, 2001.
21. Vardar E, Gunlusoy B, Minareci S, Postaci H and Ayder AR: Evaluation of p53 nuclear accumulation in low- and high-grade (WHO/ISUP Classification) transitional papillary carcinomas of the bladder for tumor recurrence and progression. Urol Int 77: 27-33, 2006.
22. Loukas CG, Wilson GD, Vojnovic B and Linney A: An image analysis-based approach for automated counting of cancer cell nuclei in tissue sections. Cytometry A 55: 30-42, 2003.
23. Yin H and Leong AS: Histologic grading of noninvasive papillary urothelial tumors. Validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Am J Clin Pathol 121: 679-687, 2004.
24. Sun W, Zhang P and Herrera G: p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder. Appl Immunohistochem Mol Morphol 10: 327-331, 2002.
25. Duensing A and Duensing S: Guilt by association? P53 and the development of aneuploidy in cancer. Biochem Biophys Res Com 331: 694-700, 2005.
26. Bol MGW, Baak JPA, van Diermen B, et al: Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial carcinomas: identification of subgroups with low and high stage progression risks. J Clin Pathol 56: 447-452, 2003.